213 related articles for article (PubMed ID: 23392000)
1. Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.
Glanz K; Volpicelli K; Kanetsky PA; Ming ME; Schuchter LM; Jepson C; Domchek SM; Armstrong K
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):607-14. PubMed ID: 23392000
[TBL] [Abstract][Full Text] [Related]
2. Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.
Aspinwall LG; Taber JM; Kohlmann W; Leaf SL; Leachman SA
Genet Med; 2014 Nov; 16(11):846-53. PubMed ID: 24763292
[TBL] [Abstract][Full Text] [Related]
3. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
Aspinwall LG; Leaf SL; Dola ER; Kohlmann W; Leachman SA
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1510-9. PubMed ID: 18559569
[TBL] [Abstract][Full Text] [Related]
5. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.
Stump TK; Aspinwall LG; Drummond DM; Taber JM; Kohlmann W; Champine M; Cassidy PB; Petrie T; Liley B; Leachman SA
Genet Med; 2020 Jan; 22(1):26-34. PubMed ID: 31371819
[TBL] [Abstract][Full Text] [Related]
7. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
8. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
[TBL] [Abstract][Full Text] [Related]
9. Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
Puig-Butille JA; Escámez MJ; Garcia-Garcia F; Tell-Marti G; Fabra À; Martínez-Santamaría L; Badenas C; Aguilera P; Pevida M; Dopazo J; del Río M; Puig S
Oncotarget; 2014 Mar; 5(6):1439-51. PubMed ID: 24742402
[TBL] [Abstract][Full Text] [Related]
10. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of melanoma genetics.
Gabree M; Patel D; Rodgers L
Curr Treat Options Oncol; 2014 Jun; 15(2):336-50. PubMed ID: 24652319
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
13. Impact of melanoma genetic test reporting on perceived control over melanoma prevention.
Aspinwall LG; Stump TK; Taber JM; Kohlmann W; Leaf SL; Leachman SA
J Behav Med; 2015 Oct; 38(5):754-65. PubMed ID: 25822116
[TBL] [Abstract][Full Text] [Related]
14. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
15. Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling.
Aspinwall LG; Leaf SL; Kohlmann W; Dola ER; Leachman SA
J Am Acad Dermatol; 2009 May; 60(5):745-57. PubMed ID: 19278751
[TBL] [Abstract][Full Text] [Related]
16. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Potrony M; Puig-Butillé JA; Aguilera P; Badenas C; Carrera C; Malvehy J; Puig S
J Am Acad Dermatol; 2014 Nov; 71(5):888-95. PubMed ID: 25064638
[TBL] [Abstract][Full Text] [Related]
18. Genetics: what advice for patients who present with a family history of melanoma?
Newton Bishop JA; Gruis NA
Semin Oncol; 2007 Dec; 34(6):452-9. PubMed ID: 18083368
[TBL] [Abstract][Full Text] [Related]
19. Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.
Stump TK; Aspinwall LG; Kohlmann W; Champine M; Hauglid J; Wu YP; Scott E; Cassidy P; Leachman SA
J Genet Couns; 2018 Aug; 27(4):955-967. PubMed ID: 29349527
[TBL] [Abstract][Full Text] [Related]
20. Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.
Taber JM; Aspinwall LG; Stump TK; Kohlmann W; Champine M; Leachman SA
J Behav Med; 2015 Oct; 38(5):740-53. PubMed ID: 26178773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
